132 related articles for article (PubMed ID: 18257153)
1. Re: Is a screening interval of every 4 years for prostate cancer acceptable?
Braillon A
J Natl Cancer Inst; 2008 Feb; 100(3):222-3; author reply 223-4. PubMed ID: 18257153
[No Abstract] [Full Text] [Related]
2. Screening for prostate cancer.
Lee TH; Kantoff PW; McNaughton-Collins MF
N Engl J Med; 2009 Mar; 360(13):e18. PubMed ID: 19297563
[No Abstract] [Full Text] [Related]
3. Re: Is a screening interval of every 4 years for prostate cancer acceptable?
Roobol MJ; Schröder FH
J Natl Cancer Inst; 2008 Feb; 100(3):222; author reply 223-4. PubMed ID: 18230797
[No Abstract] [Full Text] [Related]
4. Prostate cancer screening.
Med Lett Drugs Ther; 2008 Nov; 50(1298):85-6. PubMed ID: 18978703
[No Abstract] [Full Text] [Related]
5. Summaries for patients. Screening for prostate cancer with prostate-specific antigen testing: U.S. Preventive Services Task Force recommendations.
Ann Intern Med; 2008 Aug; 149(3):I37. PubMed ID: 18678840
[No Abstract] [Full Text] [Related]
6. PSA test not recommended by Canadian Task Force.
Tanday S
Lancet Oncol; 2014 Dec; 15(13):e589. PubMed ID: 25499287
[No Abstract] [Full Text] [Related]
7. Counseling patients about prostate cancer screening.
Foxhall LE; Von Eschenbach AC
Am Fam Physician; 2002 May; 65(9):1752, 1754, 1757. PubMed ID: 12018801
[No Abstract] [Full Text] [Related]
8. Should routine screening for prostate-specific antigen be recommended?
Oottamasathien S; Crawford ED
Arch Intern Med; 2003 Mar; 163(6):661-2; discussion 666. PubMed ID: 12639195
[No Abstract] [Full Text] [Related]
9. Summaries for patients. Screening for prostate cancer: a guidance statement from the Clinical Guidelines Committee of the American College of Physicians.
Ann Intern Med; 2013 May; 158(10):I-28. PubMed ID: 23567761
[No Abstract] [Full Text] [Related]
10. The United States Preventive Services Task Force recommendation against prostate-specific antigen screening--counterpoint.
Catalona WJ
Cancer Epidemiol Biomarkers Prev; 2012 Mar; 21(3):395-7. PubMed ID: 22315363
[No Abstract] [Full Text] [Related]
11. Screening for prostate cancer: enthusiasm.
Catalona WJ
Urology; 1993 Aug; 42(2):113-5. PubMed ID: 7690167
[No Abstract] [Full Text] [Related]
12. Screening for prostate cancer: a guidance statement from the Clinical Guidelines Committee of the American College of Physicians.
Qaseem A; Barry MJ; Denberg TD; Owens DK; Shekelle P;
Ann Intern Med; 2013 May; 158(10):761-769. PubMed ID: 23567643
[TBL] [Abstract][Full Text] [Related]
13. PSA Screening for Prostate Cancer.
Quaas J
Am Fam Physician; 2015 May; 91(9):Online. PubMed ID: 25955746
[No Abstract] [Full Text] [Related]
14. Preventive Services Task Force recommends against PSA screening after age 75.
Twombly R
J Natl Cancer Inst; 2008 Nov; 100(22):1571-3. PubMed ID: 19001606
[No Abstract] [Full Text] [Related]
15. The United States Preventive Services Task Force recommendation against prostate-specific antigen screening--point.
Ablin RJ
Cancer Epidemiol Biomarkers Prev; 2012 Mar; 21(3):391-4. PubMed ID: 22315362
[No Abstract] [Full Text] [Related]
16. Screening for prostate cancer: commentary on the recommendations of the Canadian Task Force on the Periodic Health Examination. The U.S. Preventive Services Task Force.
Am J Prev Med; 1994; 10(4):187-93. PubMed ID: 7528518
[No Abstract] [Full Text] [Related]
17. Advances in the application of prostate-specific antigen in the detection of early-stage prostate cancer.
Kamoi K; Babaian RJ
Semin Oncol; 1999 Apr; 26(2):140-9. PubMed ID: 10597725
[TBL] [Abstract][Full Text] [Related]
18. Prostate cancer. When to offer screening in the primary care setting.
Gambert SR
Geriatrics; 2001 Jan; 56(1):22-6, 29-31. PubMed ID: 11196336
[TBL] [Abstract][Full Text] [Related]
19. Screening: seeking a balance.
Lancet Oncol; 2007 Jan; 8(1):1. PubMed ID: 17196503
[No Abstract] [Full Text] [Related]
20. Risks of PSA screening now better understood.
Peres J
J Natl Cancer Inst; 2013 Nov; 105(21):1590-2. PubMed ID: 24142893
[No Abstract] [Full Text] [Related]
[Next] [New Search]
